Agoracom Blog Home

Posts Tagged ‘CBD’

Hollister Biosciences Inc. $HOLL.ca is Making & Donating Hand Sanitizer to Hollister, CA

Posted by AGORACOM-JC at 7:36 AM on Tuesday, March 24th, 2020
  • In the wake of the COVID-19 pandemic, Hollister is using its essential business standing and facility to source and produce hand sanitizer for its local community.
  • The CEO of Hollister Biosciences Inc, Carl Saling, shared: “The community of Hollister, CA is near and dear to our hearts, and as the first licensed cannabis company in the city of Hollister, CA, I feel that we must do whatever we can to help.

VANCOUVER, March 24, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – through its Hollister Cannabis Co division, is stepping up to manufacture and distribute a few thousand bottles of hand sanitizer to Hollister, CA.

A statewide “shelter at home” mandate has been issued for California, putting a halt to non-essential manufacturing and delay in distribution. Cannabis retailers and manufacturers are considered essential businesses in California. In the wake of the COVID-19 pandemic, Hollister is using its essential business standing and facility to source and produce hand sanitizer for its local community.

Hollister will be giving its first batch of hand sanitizer to the Hollister food bank. Multiple batches of hand sanitizer are expected to be delivered to community organizations over the next few weeks.

The CEO of Hollister Biosciences Inc, Carl Saling, shared: “The community of Hollister, CA is near and dear to our hearts, and as the first licensed cannabis company in the city of Hollister, CA, I feel that we must do whatever we can to help.

It infuriated me seeing companies price gouging much needed items, such as hand sanitizer.  I am all for making money, but not at the expense of playing on people’s fears during a time of crisis. We just had to act.

We are going to focus on donating to the facilities that are often overlooked: the food bank, nursing homes, rehabilitation centers, and homeless shelters, where some of the most vulnerable are sheltering in place.

I am calling all business owners to step up in this time of crisis and do whatever you can to help your local community.”

About Hollister Biosciences Inc. 

Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.” 

Website:  www.hollistercannabisco.com 

HOLLISTER BIOSCIENCES INC.: 

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile onwww.sedar.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-inc-is-making–donating-hand-sanitizer-to-hollister-ca-301028647.html

NORTHBUD $NBUD.ca – Growing Preference For #Edibles Over Smoking #Cannabis Projected To Drive Global Cannabis Edibles Market Growth $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 2:25 PM on Monday, March 23rd, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Growing Preference For Edibles Over Smoking Cannabis Projected To Drive Global Cannabis Edibles Market Growth

  • Rising approval of recreational marijuana has surged the demand for legal cannabis
  • Thus, cannabis edibles are extensively approved in nations such as Canada, the US, Chile, Spain, Germany, Australia, and Israel

Cannabis edibles can be defined as food products that comprise cannabinoids and its spinoffs. Numerous cannabis edibles entail a considerable amount of cannabinoids that assist in decreasing anxiety and fatigue along with enhancing appetite. Also, cannabis edibles assist in improving relaxation & euphoria and are administered for recreational as well as medicinal reasons. The growing acceptance of cannabis is the key factor likely to drive the growth of the global cannabis edibles market during the forecast period.

Further, these products are deemed to be effective, safe, and have intoxicating & healing impacts of cannabis with no exposure to likely threats of cannabis smoking. Consequently, this is projected to boost the expansion of the global cannabis edibles market in the upcoming period. In addition, the rising usage of cannabis edibles in beverages, baked items, chocolates, candies, lozenges, and gummies are also anticipated to contribute to the expansion of the global cannabis edibles market. With the rising recognition of these products in the nations that are making cannabis legal for medicinal purposes, the cannabis edibles market is projected to register a substantial rate of growth during the near future.

Apart from this, the rising approval of recreational marijuana has surged the demand for legal cannabis. Thus, cannabis edibles are extensively approved in nations such as Canada, the US, Chile, Spain, Germany, Australia, and Israel. The cannabis industry has surfaced in recent times as a productive business domain with a huge prospect for market expansion and is driving the attention of several new merchants and giant financiers. This is owing to the rising social recognition of cannabis-infused edibles and recreational marijuana products around the world.

Further, this has not only elevated the revenues and sales of top firms but has also considerably contributed to the revenue of numerous governments. Also, merchants are observing a rise in the growth avenues in businesses entailing cannabis edibles like ice creams, chocolates, and brownies, thereby fueling the global of the global cannabis edibles market.

Nevertheless, several cannabis extracts utilized in the making of the cannabis edibles are inclined to confront judicial scrutiny and regulatory challenges in the coming period that might obstruct the expansion of the global cannabis edibles market. Nonetheless, the elevated usage of cannabis edibles to efficiently treat several conditions such as epilepsy, cancer, chronic pain, anorexia, arthritis, multiple sclerosis, Alzheimer’s, and nausea is anticipated to cancel out the impacts of numerous market hindrances. To cite, as announced on March 18, 2020, Clovr, a Kansas City-located cannabis manufacturing firm, has collaborated with Wana Brands, a cannabis edibles giant, to get edible products to the quickly flourishing and much-awaited Missouri market. Introduced in 2010, the Colorado brand already serves Oregon, Ohio, California, Illinois, Michigan, Arizona, Oklahoma, and now Missouri, with intentions to function in Florida and Maryland. Lately, Wana Brands also set up an international footmark, getting its items to the Canadian cannabis market via a licensing pact with Indiva Limited.   Source: https://cannabisindustrynews24.com/1491/growing-preference-for-edibles-over-smoking-cannabis-projected-to-drive-global-cannabis-edibles-market-growth/

Primo $PRMO.ca Provides Corporate Update $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 2:04 PM on Monday, March 23rd, 2020
  • Cease trade order has been lifted and as of March 5, 2020 the Company is once again trading on the CSE under the symbol: PRMO
  • The Company was not subject to any insolvency proceedings

VANCOUVER, British Columbia, March 23, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has satisfied the provisions of the information guidelines of National Policy 12-203, by filing its annual financial statements and MD&A for the year ended July 31, 2019, and therefore its cease trade order has been lifted and as of March 5, 2020 the Company is once again trading on the CSE under the symbol: PRMO.  The Company was not subject to any insolvency proceedings.

The Company also announces the appointment of Mr. Mark Bechtel as Corporate Secretary.

Mr. Bechtel is a securities lawyer with extensive experience in Canadian capital markets and exchanges. Presently Mr. Bechtel operates a law firm located in downtown Vancouver specializing in venture and emerging markets. As Corporate Secretary of Primo Mr. Bechtel will ensure that best practices for regulatory compliance are established and maintained.

The Company has also entered into a consulting agreement with Sheryl Dhillon to act as their Corporate Governance consultant.   Ms. Dhillon is a highly experienced corporate secretary with over fifteen years of experience.  She has extensive knowledge of corporate governance, as well as strong management skills and excellent corporate communications.  Ms. Dhillon acts as Corporate Secretary for several TSXV and CSE listed companies.

“The addition of Mr. Bechtel and Ms. Dhillon is a significant value-add to the Primo team.  Their cumulative experience in various disciplines will further empower the Company’s growth.  It is an exciting time for our Company.”  Comments from Mr. Andy Jagpal, CEO & President.

ON BEHALF OF THE BOARD OF DIRECTORS

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at:

Ph:604-722-0305
Email:[email protected]

http://primoceuticals.com/
https://twitter.com/prmonutra
www.thriveCBD.org

FORWARD LOOKING STATEMENTS:

This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

No regulatory authority has approved or disapproved the information contained in this news release.

Mota Ventures $MOTA.ca Launching Immune Support CBD Line; Pure Herbal Immunity Blend Acquiring 1,838 New Customers Within a Week APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 12:13 PM on Monday, March 23rd, 2020

Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC:PEMTF) (the “Company” or “Mota”) is pleased to announce that since the launch of the Pure Herbal Immunity Blend under the First Class brand on March 14th, 2020, it has had an exceptional reception, acquiring 1,838 new customers.

The all-natural Immunity Blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. Due to customer demand for pure and efficacious products to support the immune system, the Company will be launching an Immune CBD oil, along with an Elderberry Gummy product on Monday, March 23rd. The new Immune CBD product contains CBD, B3, B12, Vitamin C and Zinc. Based on the success of the launch, First Class will be increasing marketing efforts throughout the US.

The Company plans to offer similar immune products in Europe through its Sativida brand, which currently retails product in various jurisdictions in Europe, including Spain, Portugal, Austria, Germany, France and the United Kingdom.

The Company anticipates the completion of the Sativida transaction in the next seven days. Further to its January 10, 2020 news release, the Company will acquire the intellectual property and trade names of Sativida from VIDA BCN LABS SL (Spain) and Sativida OU (Estonia) (collectively, “Sativida”). The Company will license both back to Sativida in exchange for a royalty associated with the gross revenues generated by Sativida.

“As our customers around the globe face challenges in their daily lives, we are working diligently to provide products to help families with natural health needs. Our supply chain is operating uninterrupted and we are quickly working to expand our immune support product line. We stand ready to continue to adapt to market changes and innovate new products to take advantage of the numerous opportunities ahead”, states Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

About Sativida

Sativida is a producer and online retailer of CBD and branded CBD products in various jurisdictions in Europe, including Spain and the United Kingdom. Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is currently expanding its distribution network internationally. For more information on Sativida, readers are encouraged to review their website, www.sativida.es.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact the President of the Company, Joel Shacker, at +604.423.4733 or by email at [email protected]or www.motaventuresco.com

INTERVIEW: Empower $CBDT.ca #CBD Clinics Designated Essential Service – February Visits Climb 800% $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:12 PM on Thursday, March 19th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 351% in Q4 and 800% in February.  But would Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower has had to actually increase operating hours.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history.  

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

Spyder #Cannabis $SPDR.ca – #COVID19 restrictions sparking a run on cannabis stores $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 3:43 PM on Tuesday, March 17th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

COVID-19 restrictions sparking a run on cannabis stores

By: Bruce Barcott and David Downs

  • They’re not closed yet! Customers are stocking up on cannabis this weekend, preparing for what could be more retail store restrictions in coming days.

As governors and mayors across North America order the shutdown of bars, restaurants, and gathering events, cannabis stores are experiencing a dramatic surge in sales that started over the weekend and now continues into the work week. (Leafly has an updated page tracking store closures, openings, and new delivery allowances.)

Consumers are stocking up now, eyeing their potential future over in Europe, where some nations have closed all retail outlets except food stores and pharmacies.

Cannabis and coronavirus: Here’s what you need to know

On Saturday, Boston’s WGBH broadcast images of customers lining up outside New England Treatment Access (NETA) in Brookline, one of the few licensed cannabis stores operating in Massachusetts. WGBH’s Tori Bedford reported:

In Brookline, marijuana dispensary New England Treatment Access has eliminated all walk-in orders due to a high volume of customers, and will now only serve customers who place orders in advance. “In light of the current environment, we will remain open,” an announcement on the NETA website reads, “but will move to Reserve Ahead only starting on Saturday.”

Inside the Brookline store, employees wear latex gloves, and bottles of hand sanitizer and disinfectant spray sit beside each checkout station. The process is efficient, a quick in-and-out, as compared to the massive lines seen snaking around the parking lot of the shop in the past few days, according to NETA employees.

Later Sunday, Boston Mayor Mary Walsh imposed new restrictions on the city’s bars and restaurants. Those establishments will have to cut their capacity in half, and close by 11pm every night. As of now, there are no unusual restrictions on cannabis stores.

Also Sunday, the governors of Ohio and Illinois ordered all bars and restaurants closed. By mid-day Monday, similar orders had been issued in too many states to mention.

Source: https://www.leafly.com/news/author/bruce-barcott-and-david-downs

NORTHBUD $NBUD.ca – Amid #coronavirus, Canadian #cannabis stores see ‘unprecedented’ sales surge $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:40 PM on Tuesday, March 17th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Amid coronavirus, Canadian cannabis stores see ‘unprecedented’ sales surge

By Matt Lamers

  • Cannabis stores in Ontario and Alberta reported “unprecedented demand” as the country hunkers down to fight a worsening coronavirus outbreak, industry sources say

Executives told Marijuana Business Daily there is no threat to supply chains at this time, and safety measures have been put into place for employees and consumers.

Spiritleaf CEO Darren Bondar said his 46 stores “experienced an unprecedented demand for cannabis over the weekend with sales up 20% over the previous one and a record number of customers served.

“The supply chain remains in place, stores are stocked and we have seen an uptick in edible purchases.”

Spiritleaf is encouraging online ordering via click-and-collect programs in British Columbia, Alberta and Ontario.

In most of Canada, provinces retain monopolies over cannabis e-commerce with delivery. The click-and-collect program allows privately owned stores to take payment online so customers can pick up their orders in stores.

Ontario up 80%

Sales surged week-over-week at Ontario’s monopoly online cannabis store, but some of that increased demand is attributable to lower prices.

The government-owned store aggressively dropped prices on some products as part of an ongoing drive to improve competitiveness.

Mike Ravkine, who operates the popular price-tracking and inventory tool WhatsMyPot, recorded significant price drops at the Ontario Cannabis Store.

“The last three days have seen a marked increase in volume in sales on OCS.ca and a high demand for our same day/next day delivery option where it is available,” Daffyd Roderick, OCS communications director, wrote in an email to Marijuana Business Daily.

“Some authorized retail stores are also reporting an increase in customer volume. Saturday saw almost 3,000 orders, an 80% increase over an average Saturday.”

The OCS’ 4,000 orders Sunday represent a 100% increase from the previous week, officials told MJBizDaily.

Roderick said the OCS has sufficient inventory to meet demand.

“We are working closely with our partners and currently delivering and receiving as per our normal schedule,” he said.

Physical stores in Ontario are also seeing an increase in orders, noted Sessions Cannabis CEO Steven Fry.

“Not unlike major grocery retailers, Sessions Cannabis has seen a significant increase in sales this week due to growing concerns regarding COVID-19 social distancing protocols,” he wrote in an email.

Compared to the previous week, Fry said the Sessions on the Beach location in Toronto saw approximately:

  • A 10% more transactions per day.
  • A 10% increase in dollars spent per transaction.
  • A 21% overall sales growth.

B.C. ‘steady’

British Columbia’s online monopoly BC Cannabis Stores has not seen any new sales trends.

A spokesperson for the BC Liquor Distribution Branch (BCLDB), which operates the store as well as the province’s cannabis wholesale system, said there has been no change in sales online.

The BCLDB spokesperson also said sales on the wholesale side remain “very flat, steady.”

Alberta Cannabis, the only legal online store in the province, said it is not sharing any information.

Quebec bump

Quebec’s monopoly online store also saw increased sales.

Société québécoise du cannabis (SQDC), which is also the wholesaler for the province, said its website remains “fully functional and parcels are still being delivered.”

“Indeed, we have seen an increase in sales over the last days,” spokesman Fabrice Giguere wrote in an email to MJBizDaily.

Giguere said inventory levels, both online and in stores, are stable.

“We invite all customers returning from a trip abroad or who experience flu-like symptoms to do their shopping directly online,” he noted.

Safety first

Physical cannabis stores are taking measures to increase the health and safety of customers and employees to support social distancing.

“Sessions Cannabis is taking extra measures to ensure the safety of our customers and staff through increased cleaning and sanitation measures and we will continue to monitor the situation to ensure a safe shopping experience,” Fry said.

Bondar said Spiritleaf continues to follow all advice and government guidelines.

“All surfaces, door handles and employee stations are being sanitized throughout the workday to maintain a clean, safe environment for all of us,” he said.

“We encourage customers to check on store hours in the event that they may change to accommodate various staff members’ needs to take care of family members or who are returning from vacation and in self-isolation, which has been happening at a few locations across the country.

Source: https://mjbizdaily.com/amid-coronavirus-canadian-cannabis-stores-see-unprecedented-sales-surge/

North Bud Farms $NBUD.ca Receives Canadian Cultivation Licence for its Quebec Facility $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:32 AM on Monday, March 16th, 2020
  • Received its standard cultivation licence from Health Canada for 24,500 sq. ft. of indoor cannabis cultivation space at its purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec
  • Receipt of this licence allows the Company to proceed with phase one (indoor cultivation) at its Quebec Facility.
  • Company will soon be filing an amendment application with Health Canada to licence an additional 1,000,000 sq. ft. of outdoor cultivation space

TORONTO, March 16, 2020 – North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its wholly-owned subsidiary, GrowPros MMP Inc., has received its standard cultivation licence from Health Canada for 24,500 sq. ft. of indoor cannabis cultivation space at its purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec (the “Quebec Facility”).  The receipt of this licence allows the Company to proceed with phase one (indoor cultivation) at its Quebec Facility.

Highlights:

  • Cultivation is expected to begin shortly with the first four months focused on establishing an inventory of mother plants and clones in preparation for the outdoor growing season that begins in late June;
  • The Company will soon be filing an amendment application with Health Canada to licence an additional 1,000,000 sq. ft. of outdoor cultivation space, which it hopes will be approved in the second quarter of 2020.  Operationalizing the outdoor cultivation space represents phase two of the Company’s strategy for its Quebec Facility;
  • The Company expects the operation of the Quebec Facility to create approximately 25 local jobs in the Gatineau Valley region of Quebec; and
  • Upon full operation of both the indoor and expected outdoor cultivation space at the Quebec Facility, the annual production is estimated to be up to 20,000,000 grams per year.

“We are extremely excited about this announcement as it represents another significant step forward in NORTHBUD’s strategy to assemble a portfolio of cost-efficient cultivation facilities located in strategic jurisdictions,” said Sean Homuth, CEO of NORTHBUD.  “The receipt of our Canadian licence now gives us active licensed facilities in California, Nevada and Canada, three of the largest and most important recreational cannabis markets in the world.  These facilities will be used for the production of NORTHBUD branded cannabis products to be sold in all three of those key jurisdictions.”

“I would like to thank our shareholders for their support over the past 18 months, as well as our team for their hard work and dedication, particularly the work of Magda Farid, our Vice President of Compliance and Quality Assurance, and Kyle Foley, our Head of Facilities Management, both of whom have been instrumental in achieving this milestone,” said Ryan Brown, Executive Chairman of NORTHBUD and CEO of GrowPros MMP Inc.  â€œWe are very proud to be the second licensed producer in the Outaouais region of Quebec.  The culmination of this project is not only important for the Company but also for the economy of the local town of Venosta, Quebec, and we look forward to strengthening our relationship with our local community as we move into the operational phase with the Quebec Facility.”

Board of Director Change 
Effective March 9, 2020, Michael Saxon has resigned from the Company’s Board of Directors due to requirements related to his new employment elsewhere.  

“I want to sincerely thank Michael for his direction and guidance since the inception of the Company and wish him well with his new role and future endeavors,” said Ryan Brown, Executive Chairman.

About North Bud Farms Inc.
North Bud Farms Inc. owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada.  Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution.  Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada.  The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com

Neither the Canadian Securities Exchange (the “CSE“) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, the status of any of the Company’s current or future licence applications with Health Canada under the Cannabis Act, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller 
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

North Bud Farms $NBUD.ca Launches its NORTHBUD Branded Products in Nevada, USA $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:11 AM on Wednesday, March 11th, 2020
  • Announced the launch of its NORTHBUD branded products into select retailers in Nevada, USA. 
  • The products are manufactured through NORTHBUD’s ownership and operating agreement with Nevada Botanical Sciences, Inc., who is licensed for cultivation, manufacturing and distribution
  • NORTHBUD products will be available in both dried flower and pre-roll formats under the NORTHBUD White, Black and Platinum brands.

TORONTO, March 11, 2020 – North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce the launch of its NORTHBUD branded products into select retailers in Nevada, USA.  The products are manufactured through NORTHBUD’s ownership and operating agreement with Nevada Botanical Sciences, Inc. (“NBS”), who is licensed for cultivation, manufacturing and distribution.

NORTHBUD Nevada Launch Strategy Update
Prior to its asset purchase transaction with NORTHBUD, previously announced on November 19, 2019, NBS had been exclusively servicing white label customers.  Over the past 3.5 months, NBS and NORTHBUD have transitioned the Nevada operations to focus on NORTHBUD branded flower products, culminating with the recent launch of NORTHBUD Black 9 Lbs Hammer (Jinxproof phenotype) in 1 gram, 3.5 gram and 7 gram formats to select retailers in Reno, Nevada.

Over the coming weeks, the Company intends to expand distribution to multiple retailers in Northern Nevada and Las Vegas. NORTHBUD products will be available in both dried flower and pre-roll formats under the NORTHBUD White, Black and Platinum brands.

With over 45 million visitors a year from all over the world, Nevada is a key market for building an internationally recognized brand, and the Company believes that it is the ideal market for the launch of its NORTHBUD products. The Nevada market is considered one of the largest and most profitable in North America with recreational sales of USD$580 million in the first full year of legalization (2017 Nevada Dept. of Taxation).

“The NORTHBUD and Bonfire Brands USA team are extremely proud to have launched our own branded products, making the state of Nevada our strategic entry point into the U.S. legal cannabis market,” said Sean Homuth, CEO of NORTHBUD. “We believe the NORTHBUD brand will offer a unique variety of products curated for experienced consumers who demand appropriately priced, high-quality cannabis flower.”

About North Bud Farms Inc.
NORTHBUD, through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space, and also has active distribution and processing licenses. The Reno, Nevada property contains a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation, and holds medical and adult-use licenses for cultivation, extraction and distribution.  Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company is pursuing a license under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, those regarding the Company’s Nevada strategy, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Hollister Biosciences $HOLL.ca Enters Letter of Intent to Acquire Alphamind $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca Brands

Posted by AGORACOM-JC at 7:02 AM on Wednesday, March 11th, 2020
  • Entered into a letter of intent on March 9th, 2020 to acquire Alphamind Brands
  • Company developing legal mushroom based natural health products and conducting R&D in conjunction with accredited universities to develop psilocybin based compounds for drug development
  • All stock purchase price is anticipated to be CDN$ 1,200,000 with such payment to be made in Hollister common stock

VANCOUVER, March 11, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce that the Company has entered into a letter of intent (the “LOI“) on March 9th, 2020 to acquire Alphamind Brands ( “Alphamind“), a company developing legal mushroom based natural health products and conducting R&D in conjunction with accredited universities to develop psilocybin based compounds for drug development.

The all stock purchase price is anticipated to be CDN$ 1,200,000 with such payment to be made in Hollister common stock. The stock price will be determined based on the greater of the 14-day VWAP (Volume Weighted Average Price) subsequent to announcing the transaction and $0.20.  The acquisition is subject to normal course due diligence. 

“We are very pleased to have entered into an LOI to complete this very exciting acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences Inc.  “It is a fundamental value of our company to improve the overall health and performance of our customers through our high-quality products and the health benefits associated with medicinal mushrooms are tremendous.  Not to mention, it is our continual objective to broaden our product scope and Alphamind, with its experienced management team, is a perfect foothold for us in the fast-growing market for medicinal mushrooms and complements our existing cannabis and hemp-based product offering.”

“I think we have found a great partner in Hollister”, shared Robert Birmingham, CEO of Alphamind Brands.  “We have medicinal mushroom based product SKU’s ready to ship and R&D is underway to develop an exciting IP portfolio surrounding psilocybin based pharmaceutical treatments. Being under the Hollister umbrella will allow us to access additional markets and leverage their existing manufacturing and distribution infrastructure and will be a fundamental part of the future growth of our business.”

In association with the arm’s length transaction, Hollister will not be assuming any long-term debt and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website: www.hollistercannabisco.com 

About Alphamind Brands

Alphamind Brands is a Canada and US based growth stage company developing a portfolio of legal mushroom based natural health products as well as conducting R&D initiatives, led by Dr. Nikos Apostolopoulos, to explore psilocybin based pharmaceutical treatments.  The company’s “ready to ship” product SKU’s include cordyceps, lion’s mane, chaga and reishi mushroom based: liquid cordyceps, concentrated mushroom powder, tea, chocolate.  The company’s product SKU’s under development include syrups, elixirs, cold beverages and nasal spray.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-enters-letter-of-intent-to-acquire-alphamind-brands-301021154.html

SOURCE Hollister Biosciences Inc.